Dext Parental Private Limited
About Dext Parental Private Limited
Data last updated:
Dext Parental Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 November 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1993PTC055978. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Pawan Thapar and Doctor Malti Thapar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 325 New Friends Colony, New Delhi, Delhi, India – 110065.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.63 Lakh, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹4.31 Lakh (net margin 24.4%) and EBITDA of ₹7.64 Lakh (EBITDA margin 43.3%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 325 New Friends Colony, New Delhi, Delhi, India – 110065
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Dext Parental Private Limited FY 2025 filings available
Dext Parental Private Limited reported revenue of ₹17.63 Lakh (up 61% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Dext Parental Private Limited
Revenue rose 61% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 198% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dext Parental Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.31 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dext Parental Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 24.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dext Parental are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dext Parental Private Limited
Dext Parental Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Balajee Meditech Private Limited | ₹17.69 Lakh (FY 2018) | •••• | •••• | 31.0% | •••• | Allahabad, Uttar Pradesh, India |
| Marksman Research & Development Private Limited | ₹17.69 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Patna, Bihar, India |
| Curapro Formulations and Hygienic Private Limited | ₹17.68 Lakh (FY 2021) | •••• | •••• | 164.0% | •••• | Chinchwad, Maharashtra, India |
| Makjai Laboratories Pvt Ltd | ₹17.68 Lakh (FY 2022) | •••• | •••• | -83.0% | •••• | Kolhapur, Maharashtra, India |
| Ba Alavi Sadath Ayurvedic Research (India) Private Limited | ₹17.67 Lakh (FY 2025) | •••• | •••• | 46.0% | •••• | Malappuram, Kerala, India |
| Dext Parental Private Limited this company | ₹17.63 Lakh (FY 2024) | •••• | •••• | 61.0% | •••• | New Delhi, Delhi, India |
| Tenshi KSM Private Limited | ₹17.6 Lakh (FY 2021) | •••• | •••• | -82.0% | •••• | Bangalore, Karnataka, India |
| Mediorals Laboratories Private Limited | ₹17.53 Lakh (FY 2016) | •••• | •••• | 1476.0% | •••• | Mumbai, Maharashtra, India |
| Eagle Laboratories Pvt Ltd | ₹17.51 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | Kolkata, West Bengal, India |
| Zyllexa Formulations Private Limited | ₹17.48 Lakh (FY 2023) | •••• | •••• | -34.0% | •••• | Bilathikulam, Kerala, India |
| Reagene Biosciences Private Limited | ₹17.47 Lakh (FY 2023) | •••• | •••• | -1.0% | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Dext Parental by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dext Parental Private Limited
Dext Parental Private Limited is audited by INDER AGARWAL ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| INDER AGARWAL ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dext Parental Private Limited
Dext Parental has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Thapar | Director | 09 Nov 1993 | 32 Years 11 Months | Current |
| Doctor Malti Thapar | Director | 09 Nov 1993 | 32 Years 11 Months | Current |
Ownership and Shareholding of Dext Parental Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dext Parental Private Limited
Dext Parental Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dext Parental Private Limited
Dext Parental Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Dext Parental Private Limited
Dext Parental has one previous CIN (Corporate Identification Number): U99999DL1993PTC055978. The current CIN is U24231DL1993PTC055978, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231DL1993PTC055978 | Current |
| U99999DL1993PTC055978 | Previous |
Recent Activity on Dext Parental Private Limited
Dext Parental Private Limited has 2 board changes on record since 1993: 2 appointments. The latest: Doctor Malti Thapar was appointed as Director on 09 Nov 1993.
Credit Ratings, Litigation & Regulatory Alerts for Dext Parental Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dext Parental Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dext Parental Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dext Parental Private Limited
Dext Parental has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dext Parental Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dext Parental Private Limited
Dext Parental is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 November 1993 (33+ years old) and is registered under CIN U24231DL1993PTC055978.
Dext Parental reported revenue of ₹17.63 Lakh for FY 2024 (up 61% YoY).
Dext Parental has 2 current directors:
- Pawan Thapar - Director
- Doctor Malti Thapar - Director
Dext Parental reported a net profit of ₹4.31 Lakh (net margin 24.4%) and EBITDA of ₹7.64 Lakh (EBITDA margin 43.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dext Parental is 10% over three years and -3% over five years. In the latest year (FY 2024) revenue rose 61%. CAGR is the steady yearly rate that links the first and the last year.
No. Dext Parental has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dext Parental is U24231DL1993PTC055978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dext Parental was incorporated on 09 November 1993, making it 33+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dext Parental by revenue are Balajee Meditech Private Limited, Marksman Research & Development Private Limited, Curapro Formulations and Hygienic Private Limited, Makjai Laboratories Pvt Ltd, Ba Alavi Sadath Ayurvedic Research (India) Private Limited and 5 more, all in the Pharma industry (Formulations).
Doctor Malti Thapar was appointed as Director on 09 Nov 1993. Pawan Thapar was appointed as Director on 09 Nov 1993.
The registered office of Dext Parental is at B – 325 New Friends Colony, New Delhi, Delhi, India – 110065.